Lysine methylation is an endogenous post-translational modification of tau protein in human brain and a modulator of aggregation propensity.
Lysine methylation is an endogenous post-translational modification of tau protein in human brain and a modulator of aggregation propensity.
复制标题
DOI:
10.1042/bj20140372
复制
发表时间:
2014-08-15
期刊:
影响因子:
--
通讯作者:
Kuret J
中科院分区:
文献类型:
--
作者:
Funk KE;Thomas SN;Schafer KN;Cooper GL;Liao Z;Clark DJ;Yang AJ;Kuret J
In Alzheimer disease, the microtubule-associated protein tau dissociates from the neuronal cytoskeleton and aggregates to form cytoplasmic inclusions. Although hyper-phosphorylation of tau Ser and Thr residues is an established trigger of tau misfunction and aggregation, tau modifications extend to Lys residues as well, raising the possibility that different modification signatures depress or promote aggregation propensity depending on site occupancy. To identify Lys-residue modifications associated with normal tau function, soluble tau proteins isolated from four cognitively normal human brains were characterized by mass spectrometry methods. The major detectable Lys modification was found to be methylation, which appeared in the form of mono- and di-methyl Lys residues distributed among at least eleven sites. Unlike tau phosphorylation sites, the frequency of Lys methylation was highest in the microtubule binding repeat region that mediates both microtubule binding and homotypic interactions. When purified recombinant human tau was modified in vitro through reductive methylation, its ability to promote tubulin polymerization was retained, whereas its aggregation propensity was greatly attenuated at both nucleation and extension steps. These data establish Lys methylation as part of the normal tau post-translational modification signature in human brain, and suggest that it can function in part to protect against pathological tau aggregation.